Replies to post #207389 on Biotech Values

[dewophile]

sgen
it could simply be a matter of risk benefit - the cascade trial is for older pts w limited options (certainly nothing curative).
allo transplants have enormous mortality and morbidity associated but is meant to be curative
i know it is holiday season but sgen really should hold a cc to clarify what they can

[genisi]

Re: SGEN SGN-CD33A AML trial clinical hold
I assume that the full clinical hold was placed on transplant eligible patients as these patients are more vulnerable either pre or post ASCT.